Tag: Antipsychotics

The cumulative evidence challenges the assumption that lifelong antipsychotic treatment is necessary or beneficial for most individuals with schizophrenia.

In this wide-ranging conversation on public mental health, psychiatrization, and community care, Dinesh Bhugra explains why meaningful lives, not symptom reduction alone, should guide mental healthcare today.

A new study published online by the Journal of Humanistic Psychology examines young adults’ experience of taking and discontinuing antipsychotic drugs after completing a...

Physician-anthropologist Khameer Kidia examines how violence and inequality shape mental distress, arguing for patient autonomy, community care, and structural change beyond diagnosis, medication, and individualized psychiatric treatment.

Justin Garson joins us to talk about the work of Solomon Snyder, whose discoveries ushered in the era of biological psychiatry.

This week Mad in America examines three studies related to the adverse effects of psychotropic drugs and one that investigates the effect of keto...

This week Mad in America examines studies related to adverse events associated with antipsychotics and antidepressants, including two studies that found increased risk of...

Long-term care facilities commonly prescribe antipsychotic drugs to elderly service users, often to treat behavioral issues associated with dementia. Despite a lack of evidence...

In this conversation, Jan DeFehr argues that ethical practice requires access to what the field itself disputes, including the risks people rarely hear about.

Musician and artist Kev G Mor joins us to discuss his experience of psychosis, his daily support strategies, and the pros and cons of having a pit bull for emotional support.

A new study in Health Expectations led by Trinity College Dublin researchers finds that people withdrawing from psychiatric medications often endure severe symptoms, limited clinical support, and widespread uncertainty about how to taper safely.

Augmenting with antipsychotics was no better at reducing suicide than adding antidepressants, but led to increased risk of death from other causes.

Older adults are often prescribed antipsychotics off-label for behavioral control in the hospital. But there’s no evidence for antipsychotics helping, and a great deal of evidence of harm.

Mental health nursing has a key role to play in helping people discontinue the drugs, writes Timothy Wand.

With pharmaceutical companies pushing antipsychotics for off-label use, dementia patients are being put at risk for devastating health consequences. Research suggests safer alternatives exist—but why aren’t they being prioritized?

The drugs, especially benzos and high doses of antipsychotics, led to an increased risk of death within five years. Antidepressants also did not reduce mortality.

A new study published in Psychology and Psychotherapy: Theory, Research and Practice finds that psychiatrists and other doctors are the most unhelpful factor for...

A new commentary published in Current Opinion in Psychiatry presents the case for slow tapering of antipsychotics. According to authors Mark Horowitz and Joanna...

New research highlights the ethical responsibilities of clinicians in supporting patients who choose to reduce or discontinue antipsychotic medication.

We should explore a raft of interventions, as susceptibility to psychosis isn’t separable from a person’s general well-being.

Those aged 18-24 had an increased risk of death within five years on doses above 100 mg chlorpromazine equivalents.

Recent research reveals how antipsychotic medications can significantly impact users' identity and self-image, challenging existing clinical approaches.

Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

New research finds insomnia, anxiety, and depression are common symptoms of antipsychotic withdrawal, highlighting difficulties of discontinuation.

A new review finds a lack of available guidance on how to effectively monitor adverse effects of antipsychotic drug clozapine.